Medical Care
Global TCR Based Therapy Market Research Report 2025
- May 05, 25
- ID: 226388
- Pages: 83
- Figures: 81
- Views: 32
The global market for TCR Based Therapy was valued at US$ 49.3 million in the year 2024 and is projected to reach a revised size of US$ 68.2 million by 2031, growing at a CAGR of 4.8% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for TCR Based Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TCR Based Therapy.
The TCR Based Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global TCR Based Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the TCR Based Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Adaptimmune Therapeutics
Alaunos Therapeutics
Bristol Myers Squibb
Cellular Biomedicine
Gilead Biosciences
GlaxoSmithKline
Immatics
Immunocore
Lion TCR
Takara Bio
Zelluna Immunotherapy
Segment by Type
Transduction of Chimeric Antigen Receptor
Transduction of TCR α/β Heterodimer
Segment by Application
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of TCR Based Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for TCR Based Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding TCR Based Therapy.
The TCR Based Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global TCR Based Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the TCR Based Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Adaptimmune Therapeutics
Alaunos Therapeutics
Bristol Myers Squibb
Cellular Biomedicine
Gilead Biosciences
GlaxoSmithKline
Immatics
Immunocore
Lion TCR
Takara Bio
Zelluna Immunotherapy
Segment by Type
Transduction of Chimeric Antigen Receptor
Transduction of TCR α/β Heterodimer
Segment by Application
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of TCR Based Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global TCR Based Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Transduction of Chimeric Antigen Receptor
1.2.3 Transduction of TCR α/β Heterodimer
1.3 Market by Application
1.3.1 Global TCR Based Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics & Ambulatory Centers
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global TCR Based Therapy Market Perspective (2020-2031)
2.2 Global TCR Based Therapy Growth Trends by Region
2.2.1 Global TCR Based Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 TCR Based Therapy Historic Market Size by Region (2020-2025)
2.2.3 TCR Based Therapy Forecasted Market Size by Region (2026-2031)
2.3 TCR Based Therapy Market Dynamics
2.3.1 TCR Based Therapy Industry Trends
2.3.2 TCR Based Therapy Market Drivers
2.3.3 TCR Based Therapy Market Challenges
2.3.4 TCR Based Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top TCR Based Therapy Players by Revenue
3.1.1 Global Top TCR Based Therapy Players by Revenue (2020-2025)
3.1.2 Global TCR Based Therapy Revenue Market Share by Players (2020-2025)
3.2 Global TCR Based Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by TCR Based Therapy Revenue
3.4 Global TCR Based Therapy Market Concentration Ratio
3.4.1 Global TCR Based Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by TCR Based Therapy Revenue in 2024
3.5 Global Key Players of TCR Based Therapy Head office and Area Served
3.6 Global Key Players of TCR Based Therapy, Product and Application
3.7 Global Key Players of TCR Based Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 TCR Based Therapy Breakdown Data by Type
4.1 Global TCR Based Therapy Historic Market Size by Type (2020-2025)
4.2 Global TCR Based Therapy Forecasted Market Size by Type (2026-2031)
5 TCR Based Therapy Breakdown Data by Application
5.1 Global TCR Based Therapy Historic Market Size by Application (2020-2025)
5.2 Global TCR Based Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America TCR Based Therapy Market Size (2020-2031)
6.2 North America TCR Based Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America TCR Based Therapy Market Size by Country (2020-2025)
6.4 North America TCR Based Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe TCR Based Therapy Market Size (2020-2031)
7.2 Europe TCR Based Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe TCR Based Therapy Market Size by Country (2020-2025)
7.4 Europe TCR Based Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific TCR Based Therapy Market Size (2020-2031)
8.2 Asia-Pacific TCR Based Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific TCR Based Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific TCR Based Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America TCR Based Therapy Market Size (2020-2031)
9.2 Latin America TCR Based Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America TCR Based Therapy Market Size by Country (2020-2025)
9.4 Latin America TCR Based Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa TCR Based Therapy Market Size (2020-2031)
10.2 Middle East & Africa TCR Based Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa TCR Based Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa TCR Based Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Adaptimmune Therapeutics
11.1.1 Adaptimmune Therapeutics Company Details
11.1.2 Adaptimmune Therapeutics Business Overview
11.1.3 Adaptimmune Therapeutics TCR Based Therapy Introduction
11.1.4 Adaptimmune Therapeutics Revenue in TCR Based Therapy Business (2020-2025)
11.1.5 Adaptimmune Therapeutics Recent Development
11.2 Alaunos Therapeutics
11.2.1 Alaunos Therapeutics Company Details
11.2.2 Alaunos Therapeutics Business Overview
11.2.3 Alaunos Therapeutics TCR Based Therapy Introduction
11.2.4 Alaunos Therapeutics Revenue in TCR Based Therapy Business (2020-2025)
11.2.5 Alaunos Therapeutics Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb TCR Based Therapy Introduction
11.3.4 Bristol Myers Squibb Revenue in TCR Based Therapy Business (2020-2025)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Cellular Biomedicine
11.4.1 Cellular Biomedicine Company Details
11.4.2 Cellular Biomedicine Business Overview
11.4.3 Cellular Biomedicine TCR Based Therapy Introduction
11.4.4 Cellular Biomedicine Revenue in TCR Based Therapy Business (2020-2025)
11.4.5 Cellular Biomedicine Recent Development
11.5 Gilead Biosciences
11.5.1 Gilead Biosciences Company Details
11.5.2 Gilead Biosciences Business Overview
11.5.3 Gilead Biosciences TCR Based Therapy Introduction
11.5.4 Gilead Biosciences Revenue in TCR Based Therapy Business (2020-2025)
11.5.5 Gilead Biosciences Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline TCR Based Therapy Introduction
11.6.4 GlaxoSmithKline Revenue in TCR Based Therapy Business (2020-2025)
11.6.5 GlaxoSmithKline Recent Development
11.7 Immatics
11.7.1 Immatics Company Details
11.7.2 Immatics Business Overview
11.7.3 Immatics TCR Based Therapy Introduction
11.7.4 Immatics Revenue in TCR Based Therapy Business (2020-2025)
11.7.5 Immatics Recent Development
11.8 Immunocore
11.8.1 Immunocore Company Details
11.8.2 Immunocore Business Overview
11.8.3 Immunocore TCR Based Therapy Introduction
11.8.4 Immunocore Revenue in TCR Based Therapy Business (2020-2025)
11.8.5 Immunocore Recent Development
11.9 Lion TCR
11.9.1 Lion TCR Company Details
11.9.2 Lion TCR Business Overview
11.9.3 Lion TCR TCR Based Therapy Introduction
11.9.4 Lion TCR Revenue in TCR Based Therapy Business (2020-2025)
11.9.5 Lion TCR Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Details
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio TCR Based Therapy Introduction
11.10.4 Takara Bio Revenue in TCR Based Therapy Business (2020-2025)
11.10.5 Takara Bio Recent Development
11.11 Zelluna Immunotherapy
11.11.1 Zelluna Immunotherapy Company Details
11.11.2 Zelluna Immunotherapy Business Overview
11.11.3 Zelluna Immunotherapy TCR Based Therapy Introduction
11.11.4 Zelluna Immunotherapy Revenue in TCR Based Therapy Business (2020-2025)
11.11.5 Zelluna Immunotherapy Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global TCR Based Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Transduction of Chimeric Antigen Receptor
1.2.3 Transduction of TCR α/β Heterodimer
1.3 Market by Application
1.3.1 Global TCR Based Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics & Ambulatory Centers
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global TCR Based Therapy Market Perspective (2020-2031)
2.2 Global TCR Based Therapy Growth Trends by Region
2.2.1 Global TCR Based Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 TCR Based Therapy Historic Market Size by Region (2020-2025)
2.2.3 TCR Based Therapy Forecasted Market Size by Region (2026-2031)
2.3 TCR Based Therapy Market Dynamics
2.3.1 TCR Based Therapy Industry Trends
2.3.2 TCR Based Therapy Market Drivers
2.3.3 TCR Based Therapy Market Challenges
2.3.4 TCR Based Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top TCR Based Therapy Players by Revenue
3.1.1 Global Top TCR Based Therapy Players by Revenue (2020-2025)
3.1.2 Global TCR Based Therapy Revenue Market Share by Players (2020-2025)
3.2 Global TCR Based Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by TCR Based Therapy Revenue
3.4 Global TCR Based Therapy Market Concentration Ratio
3.4.1 Global TCR Based Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by TCR Based Therapy Revenue in 2024
3.5 Global Key Players of TCR Based Therapy Head office and Area Served
3.6 Global Key Players of TCR Based Therapy, Product and Application
3.7 Global Key Players of TCR Based Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 TCR Based Therapy Breakdown Data by Type
4.1 Global TCR Based Therapy Historic Market Size by Type (2020-2025)
4.2 Global TCR Based Therapy Forecasted Market Size by Type (2026-2031)
5 TCR Based Therapy Breakdown Data by Application
5.1 Global TCR Based Therapy Historic Market Size by Application (2020-2025)
5.2 Global TCR Based Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America TCR Based Therapy Market Size (2020-2031)
6.2 North America TCR Based Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America TCR Based Therapy Market Size by Country (2020-2025)
6.4 North America TCR Based Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe TCR Based Therapy Market Size (2020-2031)
7.2 Europe TCR Based Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe TCR Based Therapy Market Size by Country (2020-2025)
7.4 Europe TCR Based Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific TCR Based Therapy Market Size (2020-2031)
8.2 Asia-Pacific TCR Based Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific TCR Based Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific TCR Based Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America TCR Based Therapy Market Size (2020-2031)
9.2 Latin America TCR Based Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America TCR Based Therapy Market Size by Country (2020-2025)
9.4 Latin America TCR Based Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa TCR Based Therapy Market Size (2020-2031)
10.2 Middle East & Africa TCR Based Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa TCR Based Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa TCR Based Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Adaptimmune Therapeutics
11.1.1 Adaptimmune Therapeutics Company Details
11.1.2 Adaptimmune Therapeutics Business Overview
11.1.3 Adaptimmune Therapeutics TCR Based Therapy Introduction
11.1.4 Adaptimmune Therapeutics Revenue in TCR Based Therapy Business (2020-2025)
11.1.5 Adaptimmune Therapeutics Recent Development
11.2 Alaunos Therapeutics
11.2.1 Alaunos Therapeutics Company Details
11.2.2 Alaunos Therapeutics Business Overview
11.2.3 Alaunos Therapeutics TCR Based Therapy Introduction
11.2.4 Alaunos Therapeutics Revenue in TCR Based Therapy Business (2020-2025)
11.2.5 Alaunos Therapeutics Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Details
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb TCR Based Therapy Introduction
11.3.4 Bristol Myers Squibb Revenue in TCR Based Therapy Business (2020-2025)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Cellular Biomedicine
11.4.1 Cellular Biomedicine Company Details
11.4.2 Cellular Biomedicine Business Overview
11.4.3 Cellular Biomedicine TCR Based Therapy Introduction
11.4.4 Cellular Biomedicine Revenue in TCR Based Therapy Business (2020-2025)
11.4.5 Cellular Biomedicine Recent Development
11.5 Gilead Biosciences
11.5.1 Gilead Biosciences Company Details
11.5.2 Gilead Biosciences Business Overview
11.5.3 Gilead Biosciences TCR Based Therapy Introduction
11.5.4 Gilead Biosciences Revenue in TCR Based Therapy Business (2020-2025)
11.5.5 Gilead Biosciences Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline TCR Based Therapy Introduction
11.6.4 GlaxoSmithKline Revenue in TCR Based Therapy Business (2020-2025)
11.6.5 GlaxoSmithKline Recent Development
11.7 Immatics
11.7.1 Immatics Company Details
11.7.2 Immatics Business Overview
11.7.3 Immatics TCR Based Therapy Introduction
11.7.4 Immatics Revenue in TCR Based Therapy Business (2020-2025)
11.7.5 Immatics Recent Development
11.8 Immunocore
11.8.1 Immunocore Company Details
11.8.2 Immunocore Business Overview
11.8.3 Immunocore TCR Based Therapy Introduction
11.8.4 Immunocore Revenue in TCR Based Therapy Business (2020-2025)
11.8.5 Immunocore Recent Development
11.9 Lion TCR
11.9.1 Lion TCR Company Details
11.9.2 Lion TCR Business Overview
11.9.3 Lion TCR TCR Based Therapy Introduction
11.9.4 Lion TCR Revenue in TCR Based Therapy Business (2020-2025)
11.9.5 Lion TCR Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Details
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio TCR Based Therapy Introduction
11.10.4 Takara Bio Revenue in TCR Based Therapy Business (2020-2025)
11.10.5 Takara Bio Recent Development
11.11 Zelluna Immunotherapy
11.11.1 Zelluna Immunotherapy Company Details
11.11.2 Zelluna Immunotherapy Business Overview
11.11.3 Zelluna Immunotherapy TCR Based Therapy Introduction
11.11.4 Zelluna Immunotherapy Revenue in TCR Based Therapy Business (2020-2025)
11.11.5 Zelluna Immunotherapy Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global TCR Based Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Transduction of Chimeric Antigen Receptor
Table 3. Key Players of Transduction of TCR α/β Heterodimer
Table 4. Global TCR Based Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global TCR Based Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global TCR Based Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global TCR Based Therapy Market Share by Region (2020-2025)
Table 8. Global TCR Based Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global TCR Based Therapy Market Share by Region (2026-2031)
Table 10. TCR Based Therapy Market Trends
Table 11. TCR Based Therapy Market Drivers
Table 12. TCR Based Therapy Market Challenges
Table 13. TCR Based Therapy Market Restraints
Table 14. Global TCR Based Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global TCR Based Therapy Market Share by Players (2020-2025)
Table 16. Global Top TCR Based Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TCR Based Therapy as of 2024)
Table 17. Ranking of Global Top TCR Based Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by TCR Based Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of TCR Based Therapy, Headquarters and Area Served
Table 20. Global Key Players of TCR Based Therapy, Product and Application
Table 21. Global Key Players of TCR Based Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global TCR Based Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global TCR Based Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global TCR Based Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global TCR Based Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global TCR Based Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global TCR Based Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global TCR Based Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global TCR Based Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America TCR Based Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America TCR Based Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America TCR Based Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe TCR Based Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe TCR Based Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe TCR Based Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific TCR Based Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific TCR Based Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific TCR Based Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America TCR Based Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America TCR Based Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America TCR Based Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa TCR Based Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa TCR Based Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa TCR Based Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Adaptimmune Therapeutics Company Details
Table 47. Adaptimmune Therapeutics Business Overview
Table 48. Adaptimmune Therapeutics TCR Based Therapy Product
Table 49. Adaptimmune Therapeutics Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 50. Adaptimmune Therapeutics Recent Development
Table 51. Alaunos Therapeutics Company Details
Table 52. Alaunos Therapeutics Business Overview
Table 53. Alaunos Therapeutics TCR Based Therapy Product
Table 54. Alaunos Therapeutics Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 55. Alaunos Therapeutics Recent Development
Table 56. Bristol Myers Squibb Company Details
Table 57. Bristol Myers Squibb Business Overview
Table 58. Bristol Myers Squibb TCR Based Therapy Product
Table 59. Bristol Myers Squibb Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 60. Bristol Myers Squibb Recent Development
Table 61. Cellular Biomedicine Company Details
Table 62. Cellular Biomedicine Business Overview
Table 63. Cellular Biomedicine TCR Based Therapy Product
Table 64. Cellular Biomedicine Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 65. Cellular Biomedicine Recent Development
Table 66. Gilead Biosciences Company Details
Table 67. Gilead Biosciences Business Overview
Table 68. Gilead Biosciences TCR Based Therapy Product
Table 69. Gilead Biosciences Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 70. Gilead Biosciences Recent Development
Table 71. GlaxoSmithKline Company Details
Table 72. GlaxoSmithKline Business Overview
Table 73. GlaxoSmithKline TCR Based Therapy Product
Table 74. GlaxoSmithKline Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 75. GlaxoSmithKline Recent Development
Table 76. Immatics Company Details
Table 77. Immatics Business Overview
Table 78. Immatics TCR Based Therapy Product
Table 79. Immatics Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 80. Immatics Recent Development
Table 81. Immunocore Company Details
Table 82. Immunocore Business Overview
Table 83. Immunocore TCR Based Therapy Product
Table 84. Immunocore Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 85. Immunocore Recent Development
Table 86. Lion TCR Company Details
Table 87. Lion TCR Business Overview
Table 88. Lion TCR TCR Based Therapy Product
Table 89. Lion TCR Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 90. Lion TCR Recent Development
Table 91. Takara Bio Company Details
Table 92. Takara Bio Business Overview
Table 93. Takara Bio TCR Based Therapy Product
Table 94. Takara Bio Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 95. Takara Bio Recent Development
Table 96. Zelluna Immunotherapy Company Details
Table 97. Zelluna Immunotherapy Business Overview
Table 98. Zelluna Immunotherapy TCR Based Therapy Product
Table 99. Zelluna Immunotherapy Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 100. Zelluna Immunotherapy Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. TCR Based Therapy Picture
Figure 2. Global TCR Based Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global TCR Based Therapy Market Share by Type: 2024 VS 2031
Figure 4. Transduction of Chimeric Antigen Receptor Features
Figure 5. Transduction of TCR α/β Heterodimer Features
Figure 6. Global TCR Based Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global TCR Based Therapy Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Clinics & Ambulatory Centers Case Studies
Figure 10. Cancer Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. TCR Based Therapy Report Years Considered
Figure 13. Global TCR Based Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global TCR Based Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global TCR Based Therapy Market Share by Region: 2024 VS 2031
Figure 16. Global TCR Based Therapy Market Share by Players in 2024
Figure 17. Global Top TCR Based Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TCR Based Therapy as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by TCR Based Therapy Revenue in 2024
Figure 19. North America TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America TCR Based Therapy Market Share by Country (2020-2031)
Figure 21. United States TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe TCR Based Therapy Market Share by Country (2020-2031)
Figure 25. Germany TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific TCR Based Therapy Market Share by Region (2020-2031)
Figure 33. China TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America TCR Based Therapy Market Share by Country (2020-2031)
Figure 41. Mexico TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa TCR Based Therapy Market Share by Country (2020-2031)
Figure 45. Turkey TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Adaptimmune Therapeutics Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 49. Alaunos Therapeutics Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 50. Bristol Myers Squibb Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 51. Cellular Biomedicine Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 52. Gilead Biosciences Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 53. GlaxoSmithKline Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 54. Immatics Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 55. Immunocore Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 56. Lion TCR Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 57. Takara Bio Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 58. Zelluna Immunotherapy Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global TCR Based Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Transduction of Chimeric Antigen Receptor
Table 3. Key Players of Transduction of TCR α/β Heterodimer
Table 4. Global TCR Based Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global TCR Based Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global TCR Based Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global TCR Based Therapy Market Share by Region (2020-2025)
Table 8. Global TCR Based Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global TCR Based Therapy Market Share by Region (2026-2031)
Table 10. TCR Based Therapy Market Trends
Table 11. TCR Based Therapy Market Drivers
Table 12. TCR Based Therapy Market Challenges
Table 13. TCR Based Therapy Market Restraints
Table 14. Global TCR Based Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global TCR Based Therapy Market Share by Players (2020-2025)
Table 16. Global Top TCR Based Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TCR Based Therapy as of 2024)
Table 17. Ranking of Global Top TCR Based Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by TCR Based Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of TCR Based Therapy, Headquarters and Area Served
Table 20. Global Key Players of TCR Based Therapy, Product and Application
Table 21. Global Key Players of TCR Based Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global TCR Based Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global TCR Based Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global TCR Based Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global TCR Based Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global TCR Based Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global TCR Based Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global TCR Based Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global TCR Based Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America TCR Based Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America TCR Based Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America TCR Based Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe TCR Based Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe TCR Based Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe TCR Based Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific TCR Based Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific TCR Based Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific TCR Based Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America TCR Based Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America TCR Based Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America TCR Based Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa TCR Based Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa TCR Based Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa TCR Based Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Adaptimmune Therapeutics Company Details
Table 47. Adaptimmune Therapeutics Business Overview
Table 48. Adaptimmune Therapeutics TCR Based Therapy Product
Table 49. Adaptimmune Therapeutics Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 50. Adaptimmune Therapeutics Recent Development
Table 51. Alaunos Therapeutics Company Details
Table 52. Alaunos Therapeutics Business Overview
Table 53. Alaunos Therapeutics TCR Based Therapy Product
Table 54. Alaunos Therapeutics Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 55. Alaunos Therapeutics Recent Development
Table 56. Bristol Myers Squibb Company Details
Table 57. Bristol Myers Squibb Business Overview
Table 58. Bristol Myers Squibb TCR Based Therapy Product
Table 59. Bristol Myers Squibb Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 60. Bristol Myers Squibb Recent Development
Table 61. Cellular Biomedicine Company Details
Table 62. Cellular Biomedicine Business Overview
Table 63. Cellular Biomedicine TCR Based Therapy Product
Table 64. Cellular Biomedicine Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 65. Cellular Biomedicine Recent Development
Table 66. Gilead Biosciences Company Details
Table 67. Gilead Biosciences Business Overview
Table 68. Gilead Biosciences TCR Based Therapy Product
Table 69. Gilead Biosciences Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 70. Gilead Biosciences Recent Development
Table 71. GlaxoSmithKline Company Details
Table 72. GlaxoSmithKline Business Overview
Table 73. GlaxoSmithKline TCR Based Therapy Product
Table 74. GlaxoSmithKline Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 75. GlaxoSmithKline Recent Development
Table 76. Immatics Company Details
Table 77. Immatics Business Overview
Table 78. Immatics TCR Based Therapy Product
Table 79. Immatics Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 80. Immatics Recent Development
Table 81. Immunocore Company Details
Table 82. Immunocore Business Overview
Table 83. Immunocore TCR Based Therapy Product
Table 84. Immunocore Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 85. Immunocore Recent Development
Table 86. Lion TCR Company Details
Table 87. Lion TCR Business Overview
Table 88. Lion TCR TCR Based Therapy Product
Table 89. Lion TCR Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 90. Lion TCR Recent Development
Table 91. Takara Bio Company Details
Table 92. Takara Bio Business Overview
Table 93. Takara Bio TCR Based Therapy Product
Table 94. Takara Bio Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 95. Takara Bio Recent Development
Table 96. Zelluna Immunotherapy Company Details
Table 97. Zelluna Immunotherapy Business Overview
Table 98. Zelluna Immunotherapy TCR Based Therapy Product
Table 99. Zelluna Immunotherapy Revenue in TCR Based Therapy Business (2020-2025) & (US$ Million)
Table 100. Zelluna Immunotherapy Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. TCR Based Therapy Picture
Figure 2. Global TCR Based Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global TCR Based Therapy Market Share by Type: 2024 VS 2031
Figure 4. Transduction of Chimeric Antigen Receptor Features
Figure 5. Transduction of TCR α/β Heterodimer Features
Figure 6. Global TCR Based Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global TCR Based Therapy Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Clinics & Ambulatory Centers Case Studies
Figure 10. Cancer Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. TCR Based Therapy Report Years Considered
Figure 13. Global TCR Based Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global TCR Based Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global TCR Based Therapy Market Share by Region: 2024 VS 2031
Figure 16. Global TCR Based Therapy Market Share by Players in 2024
Figure 17. Global Top TCR Based Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TCR Based Therapy as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by TCR Based Therapy Revenue in 2024
Figure 19. North America TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America TCR Based Therapy Market Share by Country (2020-2031)
Figure 21. United States TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe TCR Based Therapy Market Share by Country (2020-2031)
Figure 25. Germany TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific TCR Based Therapy Market Share by Region (2020-2031)
Figure 33. China TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America TCR Based Therapy Market Share by Country (2020-2031)
Figure 41. Mexico TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa TCR Based Therapy Market Share by Country (2020-2031)
Figure 45. Turkey TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE TCR Based Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Adaptimmune Therapeutics Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 49. Alaunos Therapeutics Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 50. Bristol Myers Squibb Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 51. Cellular Biomedicine Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 52. Gilead Biosciences Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 53. GlaxoSmithKline Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 54. Immatics Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 55. Immunocore Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 56. Lion TCR Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 57. Takara Bio Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 58. Zelluna Immunotherapy Revenue Growth Rate in TCR Based Therapy Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232